Efavirenz Tablet, Film Coated
Product Images NDC 69097-301

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Efavirenz (NDC 69097-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fd28d7f3 45a8 429d B719 173b3e31812b 01

Chemical structure diagram of Efavirenz, showing its molecular framework including chlorine, trifluoromethyl, and cyclopropylethynyl groups. The structure depicts the arrangement of atoms and bonds characteristic of Efavirenz's active ingredient.*

FDA Label Image

Fd28d7f3 45a8 429d B719 173b3e31812b 02

The packaging label for Efavirenz Tablets, USP 600 mg, film-coated tablets for oral use. The label includes dosage information, storage instructions, and a warning to pharmacists not to cover the alert box about medicines contraindicated with Efavirenz. The label shows the product is manufactured by Cipla Ltd., India, for Cipla USA Inc., with a package count of 30 tablets and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.